COVID-19 Vaccine Text Outreach
- Conditions
- Covid19
- Registration Number
- NCT04834726
- Lead Sponsor
- University of Pennsylvania
- Brief Summary
- This project aims to evaluate different approaches to increase COVID-19 vaccine uptake among at-risk patients at Penn Medicine in an equitable and systematic manner through a centralized outreach program. The investigators will evaluate different text-based scheduling and messaging approaches informed by behavioral science to increase uptake among eligible patients, including the use of clinician endorsement, opt-out framing, and scarcity. 
- Detailed Description
- This project will evaluate a centralized approach to increasing COVID through direct outreach to eligible patients via text messaging. This pragmatic randomized controlled trial has the following aims: 
 Aim 1: To conduct systematic large scale text message outreach for vaccine delivery among a defined group of Penn Medicine in a way that advances equity.
 Aim 2: To offer different scheduling workflows through text messaging that might increase uptake and reduce disparities.
 Aim 3: To compare the equity and efficiency of different messages informed by behavioral science, including PCP endorsement, opt-out framing, and scarcity.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 19554
- patients of Penn Medicine aged 18+ who reside in Philadelphia and who have had at least 1 visit in the past 5 years with a Penn Medicine primary care provider (PCP)
- Patients who have completed any dose of the vaccine at Penn Medicine, are currently scheduled to receive the vaccine, have externally documented vaccination records, or have previously received text-message based vaccine outreach.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- FACTORIAL
- Primary Outcome Measures
- Name - Time - Method - Dose 1 Completion - 1 month - Percentage of patients who complete the first dose of the COVID vaccine within 1 month of initial outreach 
- Secondary Outcome Measures
- Name - Time - Method - Vaccine Completion - 2 months - Percentage of patients who complete the vaccination process within 2 months of initial outreach - Dose 1 Completion - 2 months - Percentage of patients who complete the first dose of the COVID vaccine within 2 months of initial outreach 
Trial Locations
- Locations (1)
- Hospital of the University of Pennsylvania 🇺🇸- Philadelphia, Pennsylvania, United States Hospital of the University of Pennsylvania🇺🇸Philadelphia, Pennsylvania, United States
